Published in AIDS Weekly, September 27th, 1999
Professor Andrew McMichael, of John Radcliffe Hospital in Oxford, who is heading the research, said the dual vaccine, which is designed to stimulate T cells in the immune system, is one of several preventive vaccines being tested or developed against the virus that has infected 35 million people worldwide.
The first part of his vaccine should go into trials in April 2000 and the second part in July. It will also be tested in Africa.
"We will start in Oxford and hopefully run the Nairobi end about four months later so they...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.